Latest Revenue Growth News

Harmoney has reaffirmed its FY26 cash NPAT guidance of $13 million, propelled by robust loan origination growth, margin improvements, and operational efficiencies from its Stellare® 2.0 platform.

Global Health Limited boosted customer receipts by 25% in the March quarter while slashing operating cash burn by 50%, setting the stage for positive cashflow from July 2026 driven by AI-enhanced efficiencies and expanding SaaS integrations.

Treasury Wine Estates is reshaping its global operations into four regional divisions to sharpen market execution and efficiency. The company reports improved third-quarter sales in China and the US, bolstered by luxury brand Penfolds, while securing $300 million in new debt to strengthen liquidity beyond $1 billion by fiscal 2026 end.

Freelancer Limited’s 1Q26 saw a 14% rise in group GMV to $263.3 million but a 9.4% revenue drop, weighed down by currency headwinds and security-driven user friction. Escrow.com posted record operating profit, while Loadshift grew revenue and media presence amid operational gains.

StepChange Holdings delivered a robust $15.18 million in unaudited revenue and $1.46 million EBITDA in Q3 2026, driven by organic growth and the BroadReach acquisition. Margin improvements and AI integration highlight its evolving consulting model.

Rent.com.au has achieved a milestone with its first-ever positive operating cashflow of $0.5 million in Q3 FY26, alongside record quarterly revenue of $1.2 million and a 168% surge in recurring revenue.

Advanced Braking Technology Ltd (ASX: ABV) reported a 28% jump in product sales revenue to $6 million for Q3 FY26, driven by strong aftermarket sales and international market traction. The company also advanced certification of its autonomous BRAKEiQ system, targeting FY27 adoption.

EBOS Group has trimmed its FY26 underlying EBITDA forecast by up to AUD 15 million due to surging fuel and logistics expenses, while maintaining its commitment to healthcare supply continuity.

Energy Action Limited posted a milestone quarter ending March 2026, delivering positive operating cash flow for the first time in FY26 alongside strong revenue gains and a notable $0.5 million debt repayment. Governance changes add a layer of uncertainty ahead of a scheduled general meeting.

Bioxyne Limited posted a record $21.3 million revenue in Q3 FY26, driven by strong demand for medicinal cannabis and psychedelics. The company secured a manufacturing agreement with Aurora Cannabis and initial orders for GMP psilocybin capsules, reaffirming FY26 guidance.

Atlas Arteria reported a modest 0.1% increase in proportionate toll revenue for Q1 2026, reflecting uneven traffic patterns across its global toll road portfolio. Strong growth on the A79 and Dulles Greenway contrasted with declines at APRR and Warnow Tunnel.

Vitura Health’s telehealth arm, Doctors on Demand, has hit a major milestone of over 1 million consultations since FY2024, while delivering sustained EBITDA profitability and a 54% revenue increase over two years to $21.6 million in FY2026 Q1-Q3.